CBS 2019
CBSMD教育中心
中 文

Cardio-Oncology

Abstract

Recommended Article

Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of ERBB2-Positive Breast Cancer Long-Term Outcomes of Patients With Mediastinal Radiation–Associated Coronary Artery Disease Undergoing Coronary Revascularization With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Venous and Arterial Thromboembolism in Patients With Cancer: JACC: CardioOncology State-of-the-Art Review Cardio-Oncology: How New Targeted Cancer Therapies and Precision Medicine Can Inform Cardiovascular Discovery Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients With Cancer Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy Drug-Drug Interactions of Common Cardiac Medications and Chemotherapeutic Agents Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients

Original Research2013 Mar 19;108(5):1071-8.

JOURNAL:Br J Cancer. Article Link

Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs

van Leeuwen RW, Brundel DH, Neef C et al. Keywords: cardio-oncology; drug interaction; prevalence; oral anticancer drug;

FULL TEXT PDF